WESTBROOK, Maine, Jan.13, 2014 /PRNewswire/ --IDEXX Laboratories, Inc. (NASDAQ: IDXX) announces a significant new addition to its leading line of point-of-care instruments, the Catalyst One' Chemistry ...

WESTBROOK, Maine, Jan. 13, 2014 /PRNewswire/ -- IDEXX Laboratories, Inc. announces a significant new addition to its leading line of point-of-care instruments, the Catalyst One(TM) Chemistry ...

IDEXX Laboratories, Inc. IDXX has announced the commercial launch of its Catalyst SDMA Test to all North American customers, scheduled on Jan 16,.

The Catalyst® Cortisol Test provides veterinarians with real-time critical insights when evaluating dogs for Addison's disease and Cushing's syndrome WESTBROOK, Maine, June 5, 2025 /PRNewswire ...

IDEXX Laboratories, Inc. IDXX recently launched the Catalyst Pancreatic Lipase Test, a single-slide solution for canine and feline patients suspected of pancreatitis. With the innovative load-and ...

IDEXX Laboratories, Inc. (NASDAQ: IDXX) announces a significant new addition to its leading line of point-of-care instruments, the Catalyst One™ Chemistry Analyzer. Engineered to ...

IDEXX Laboratories, Inc. IDXX has announced the commercial launch of its Catalyst SDMA Test to all North American customers, scheduled on Jan 16, 2018. With this, IDEXX’s point-of-care customers ...

--IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, today announced the launch of the Catalyst ® Cortisol Test, which measures real-time quantitative cortisol concentrations ...

IDEXX Laboratories, Inc. IDXX recently launched the Catalyst Pancreatic Lipase Test, a single-slide solution for canine and feline patients suspected of pancreatitis. With the innovative load-and-go ...